Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: Books From California, Simi Valley, CA, Estados Unidos de America
EUR 4,51
Cantidad disponible: 7 disponibles
Añadir al carritopaperback. Condición: Fine.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: Books From California, Simi Valley, CA, Estados Unidos de America
EUR 4,51
Cantidad disponible: 2 disponibles
Añadir al carritopaperback. Condición: Very Good. Cover and edges may have some wear.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 25,00
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 27,39
Cantidad disponible: 2 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 26,53
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 25,96
Cantidad disponible: 2 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.
Idioma: Inglés
Publicado por National Academies Press, Washington, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
EUR 33,52
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: Chiron Media, Wallingford, Reino Unido
EUR 22,31
Cantidad disponible: 2 disponibles
Añadir al carritopaperback. Condición: New.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 25,31
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: Revaluation Books, Exeter, Reino Unido
EUR 27,37
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback. Condición: Brand New. 244 pages. 6.10x0.60x9.10 inches. In Stock.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 27,84
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 28,96
Cantidad disponible: 2 disponibles
Añadir al carritoPaperback / softback. Condición: New. New copy - Usually dispatched within 3 working days.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
EUR 37,07
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New. 2025. paperback. . . . . .
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de America
EUR 46,28
Cantidad disponible: 2 disponibles
Añadir al carritoCondición: New. 2025. paperback. . . . . . Books ship from the US and Ireland.
Idioma: Inglés
Publicado por National Academies Press, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: Revaluation Books, Exeter, Reino Unido
EUR 48,00
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Brand New. 244 pages. 6.10x0.60x9.10 inches. In Stock.
Idioma: Inglés
Publicado por National Academies Press, Washington, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: CitiRetail, Stevenage, Reino Unido
EUR 29,61
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Idioma: Inglés
Publicado por National Academies Press, Washington, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: AussieBookSeller, Truganina, VIC, Australia
EUR 51,20
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: new. Paperback. The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.To better understand these gaps, Gates Ventures and the Peterson Center on Healthcare asked the National Academies to examine current challenges and offer strategies and recommendations for improvement. The resulting report emphasizes that current research prioritization does not systematically account for disease burden and unmet needs, and describes how a robust, timely, accessible data system is needed. It also explores the ways in which implementing recommended policy changes could deliver better health outcomes. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Idioma: Inglés
Publicado por National Academies Press Sep 2025, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 35,15
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware - The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.